FDA Inspection 880722 — Wickliffe Pharmaceutical Inc

Wickliffe Pharmaceutical Inc — FEI 3002992930

The FDA completed an inspection of Wickliffe Pharmaceutical Inc on May 22, 2014 in Lexington, KY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 22, 2014
Fiscal Year
2014
Product Type
Veterinary
Project Area
Pre-Approval Eval. of Animal Drugs and Food Additives
Location
Lexington, KY (United States)